Cover Image
市場調查報告書

Humanetics Corporation - 商品開發平台評估

Humanetics Corporation - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224678
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
Humanetics Corporation - 商品開發平台評估 Humanetics Corporation - Product Pipeline Review - 2015
出版日期: 2015年09月23日 內容資訊: 英文 28 Pages
簡介

Humanetics Corporation正在研發並商品化疾病預防和治療用藥物、自我施打型的生物活性化合物等。該公司所提供的藥物有隔絕放射線治療的不良影響、從營養方面支援受創傷後壓力症候群所苦的患者,以及維持神經胰島素功能低落的患者的認知機能之物。

本報告提供Humanetics Corporation的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Advenchen Laboratories, LLC的基本資料

  • Humanetics Corporation概要
  • 主要資訊
  • 企業資料

Advenchen Laboratories, LLC:R&D概要

  • 主要的治療範圍

Advenchen Laboratories, LLC:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Advenchen Laboratories, LLC:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Advenchen Laboratories, LLC:藥物簡介

  • BIO-300
  • NIC-515
  • 7-Keto

Advenchen Laboratories, LLC:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Advenchen Laboratories, LLC:最近的開發平台趨勢

Advenchen Laboratories, LLC:暫停中的計劃

Advenchen Laboratories, LLC:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07595CDB

Summary

Global Markets Direct's, 'Humanetics Corporation - Product Pipeline Review - 2015', provides an overview of the Humanetics Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Humanetics Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Humanetics Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Humanetics Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Humanetics Corporation's pipeline products

Reasons to buy

  • Evaluate Humanetics Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Humanetics Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Humanetics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Humanetics Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Humanetics Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Humanetics Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Humanetics Corporation Snapshot
    • Humanetics Corporation Overview
    • Key Information
    • Key Facts
  • Humanetics Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • Humanetics Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Humanetics Corporation - Pipeline Products Glance
    • Humanetics Corporation - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Humanetics Corporation - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
  • Humanetics Corporation - Drug Profiles
    • NIC-515
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HL-9001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BIO-300
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Humanetics Corporation - Pipeline Analysis
    • Humanetics Corporation - Pipeline Products by Target
    • Humanetics Corporation - Pipeline Products by Route of Administration
    • Humanetics Corporation - Pipeline Products by Molecule Type
    • Humanetics Corporation - Pipeline Products by Mechanism of Action
  • Humanetics Corporation - Recent Pipeline Updates
  • Humanetics Corporation - Dormant Projects
  • Humanetics Corporation - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Humanetics Corporation, Key Information
  • Humanetics Corporation, Key Facts
  • Humanetics Corporation - Pipeline by Indication, 2015
  • Humanetics Corporation - Pipeline by Stage of Development, 2015
  • Humanetics Corporation - Monotherapy Products in Pipeline, 2015
  • Humanetics Corporation - Phase II, 2015
  • Humanetics Corporation - Phase I, 2015
  • Humanetics Corporation - IND/CTA Filed, 2015
  • Humanetics Corporation - Preclinical, 2015
  • Humanetics Corporation - Pipeline by Target, 2015
  • Humanetics Corporation - Pipeline by Route of Administration, 2015
  • Humanetics Corporation - Pipeline by Molecule Type, 2015
  • Humanetics Corporation - Pipeline Products by Mechanism of Action, 2015
  • Humanetics Corporation - Recent Pipeline Updates, 2015
  • Humanetics Corporation - Dormant Developmental Projects,2015

List of Figures

  • Humanetics Corporation - Pipeline by Top 10 Indication, 2015
  • Humanetics Corporation - Pipeline by Stage of Development, 2015
  • Humanetics Corporation - Monotherapy Products in Pipeline, 2015
  • Humanetics Corporation - Pipeline by Top 10 Target, 2015
  • Humanetics Corporation - Pipeline by Top 10 Route of Administration, 2015
  • Humanetics Corporation - Pipeline by Top 10 Molecule Type, 2015
  • Humanetics Corporation - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top